A new diagnostic approach to better identify antiphospholipid syndrome

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 2, 2008, Pages 387-392

  Faricelli, Raffaella ^a,d   Esposito, S ^a   Toniato, E ^b   Flacco, M ^a   Conti, P ^b   Martinotti, S ^b   Robuffo, I ^c  

^a SS Annunziata Hospital   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c CNR   (Italy)

^d Ospedale SS Annunziata   (Italy)

Author keywords

Anti cardiolipin; Anti prothrombin; Anti 2 glycoprotein I; Antiphospholipid syndrome; APS; Immunoenzimatic assay

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PLASMA PROTEIN;

ADULT; ANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNE DISEASE; BRAIN DISEASE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; THROMBOSIS; VEIN THROMBOSIS;

EID: 47249110237     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100217     Document Type: Article

References (12)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346:752-63.
2. Cervera R, Piette JC, Font J, Khamastra MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen R, De Groot PG, Gromnica-Ihle E, Baleva M, Bombardieri S, Houssiau F, Quere I, Gris JC, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A Boffa MC, Hughes GR, Ingelmo M Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expressione in a cohort of 1,000 patients. Arthritis Rheum 2002; 46:1019-27.
3. Branch DW. Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 1994; 3:275-80.
4. Provenzale JM, Barboriak DP, Allen NB, Ortel TL. Antiphospholipid antibodies: findings at arteriography. AJNR Am J Neuroradiol 1998; 19:611-16.
5. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anti-cardiolipin antibody test. Arch Intern Med 1986; 146:2153-6.
6. Pugliese L, Bernardini I, Pacifico E, Viola-Magni M, Albi E. Antiphospholipid antibodies in patients with cancer. Int J Immunopathol Pharmacol 2006; 19:879-88.
7. Tietjen GE, Day M, Norris L, Aurora S, Halvorsen A, Schultz LR, Levine SR. Role of anti-cardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology 1998; 50:1433-40.
8. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-soto A, Tolosa C, Franz J, Selva A, Ingelmo M, Vilardell M, Hughes GRV. Am J Med 1994; 96:3-9.
9. McLaurin EY, Holliday SL, Williams P, Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64:297-303.
10. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4(2):295-306.
11. Sugi T, McIntyre JA Autoantibodies to phosphatidilethanolamine (PE) recognize a kininogen-PE complex. Blood 1995; 86:3083-3089.
12. Krilis SA, Sheng YH, Kandiah DA The role of β2-glycoprotein I in the anti-phospholipid syndrome. Lupus 1996; 5:150-152.